[1]
Henriquez-Camacho C, Gotuzzo E, Echevarria J, White AC Jr, Terashima A, Samalvides F, Pérez-Molina JA, Plana MN. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. The Cochrane database of systematic reviews. 2016 Jan 18:2016(1):CD007745. doi: 10.1002/14651858.CD007745.pub3. Epub 2016 Jan 18
[PubMed PMID: 26778150]
Level 1 (high-level) evidence
[2]
Movahedi F, Li L, Gu W, Xu ZP. Nanoformulations of albendazole as effective anticancer and antiparasite agents. Nanomedicine (London, England). 2017 Oct:12(20):2555-2574. doi: 10.2217/nnm-2017-0102. Epub 2017 Sep 28
[PubMed PMID: 28954575]
[3]
Chai JY, Jung BK, Hong SJ. Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update. The Korean journal of parasitology. 2021 Jun:59(3):189-225. doi: 10.3347/kjp.2021.59.3.189. Epub 2021 Jun 21
[PubMed PMID: 34218593]
[4]
Keller L, Welsche S, Patel C, Sayasone S, Ali SM, Ame SM, Hattendorf J, Hürlimann E, Keiser J. Long-term outcomes of ivermectin-albendazole versus albendazole alone against soil-transmitted helminths: Results from randomized controlled trials in Lao PDR and Pemba Island, Tanzania. PLoS neglected tropical diseases. 2021 Jun:15(6):e0009561. doi: 10.1371/journal.pntd.0009561. Epub 2021 Jun 30
[PubMed PMID: 34191812]
Level 1 (high-level) evidence
[6]
Zhang H, Liu C, Zheng Q. Development and application of anthelminthic drugs in China. Acta tropica. 2019 Dec:200():105181. doi: 10.1016/j.actatropica.2019.105181. Epub 2019 Sep 19
[PubMed PMID: 31542370]
[7]
Sawatdee S, Atipairin A, Sae Yoon A, Srichana T, Changsan N, Suwandecha T. Formulation Development of Albendazole-Loaded Self-Microemulsifying Chewable Tablets to Enhance Dissolution and Bioavailability. Pharmaceutics. 2019 Mar 20:11(3):. doi: 10.3390/pharmaceutics11030134. Epub 2019 Mar 20
[PubMed PMID: 30897738]
[8]
Nagy J, Schipper HG, Koopmans RP, Butter JJ, Van Boxtel CJ, Kager PA. Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability. The American journal of tropical medicine and hygiene. 2002 Mar:66(3):260-3
[PubMed PMID: 12139218]
[9]
Romo ML, Carpio A, Kelvin EA. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel? Journal of clinical pharmacology. 2014 Apr:54(4):361-7. doi: 10.1002/jcph.269. Epub 2014 Jan 25
[PubMed PMID: 24443292]
[10]
Veraldi S, Francia C, La Vela V, Nazzaro G, Barbareschi M. Telogen effluvium after oral albendazole. Clinical and experimental dermatology. 2012 Jul:37(5):565-7. doi: 10.1111/j.1365-2230.2011.04267.x. Epub 2012 Mar 15
[PubMed PMID: 22420487]
[11]
Speich B, Ali SM, Ame SM, Bogoch II, Alles R, Huwyler J, Albonico M, Hattendorf J, Utzinger J, Keiser J. Efficacy and safety of albendazole plus ivermectin, albendazole plus mebendazole, albendazole plus oxantel pamoate, and mebendazole alone against Trichuris trichiura and concomitant soil-transmitted helminth infections: a four-arm, randomised controlled trial. The Lancet. Infectious diseases. 2015 Mar:15(3):277-84. doi: 10.1016/S1473-3099(14)71050-3. Epub 2015 Jan 12
[PubMed PMID: 25589326]
Level 1 (high-level) evidence
[12]
Xing F, Ye H, Yang J, Chan JF, Seto WK, Pai PM, Yuen KY, Hung DL. Fatal pancytopenia due to albendazole treatment for strongyloidiasis. IDCases. 2018:12():112-116. doi: 10.1016/j.idcr.2018.04.002. Epub 2018 Apr 4
[PubMed PMID: 29942764]
Level 3 (low-level) evidence
[13]
Choi JS, Han JY, Ahn HK, Ryu HM, Koren G. Foetal outcomes after exposure to albendazole in early pregnancy. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 2017 Nov:37(8):1108-1111. doi: 10.1080/01443615.2017.1326886. Epub 2017 Aug 1
[PubMed PMID: 28760057]
[14]
Dayan AD. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta tropica. 2003 May:86(2-3):141-59
[PubMed PMID: 12745134]
[15]
Curtiss P, Cobos G, Sicco KL, Seminara N. Acute Alopecia Associated With Albendazole Toxicosis. Cutis. 2022 May:109(5):E43-E45. doi: 10.12788/cutis.0548. Epub
[PubMed PMID: 35856765]
[16]
Garg D, Sharma S. Albendazole for Neurocysticercosis in Children: How Long is Long Enough? Indian pediatrics. 2022 Dec 15:59(12):909-910
[PubMed PMID: 36511204]
[17]
Jacob J, Steel A, Lin Z, Berger F, Zöeller K, Jarvi S. Clinical Efficacy and Safety of Albendazole and Other Benzimidazole Anthelmintics for Rat Lungworm Disease (Neuroangiostrongyliasis): A Systematic Analysis of Clinical Reports and Animal Studies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2022 Apr 9:74(7):1293-1302. doi: 10.1093/cid/ciab730. Epub
[PubMed PMID: 34448480]
Level 3 (low-level) evidence